Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation. Issue 6 (13th May 2021)

• Record Type: Journal Article
• Authors: Lugo-Gavidia, Leslie Marisol; Burger, Dylan; Matthews, Vance B.; Nolde, Janis M.; Galindo Kiuchi, Márcio; Carnagarin, Revathy; Kannenkeril, Dennis; Chan, Justine; Joyson, Anu; Herat, Lakshini Y.; Azzam, Omar; Schlaich, Markus P.
• Is Part Of: Hypertension. Volume 77:Issue 6(2021)
• Page Start: 1825
• Page End: 1844
• Publication Date: 2021-05-13
• Subjects: biomarkers -- cardiovascular diseases -- endothelium -- inflammation -- vascular diseases; Hypertension -- Periodicals; Hypertension -- Treatment -- Periodicals; 616.132005
• DOI: 10.1161/HYPERTENSIONAHA.121.16975
• Languages: English
• ISSNs: 0194-911X

Abstract

Abstract : Microparticles are small cell vesicles that are derived from the cell membrane in response to different biological processes. There is growing evidence supporting the association between microparticles and cardiovascular disease, as their pathophysiology commonly includes endothelial damage and chronic inflammation which also promote a prothrombotic state. The direct causal link between the release of the different subtypes of microparticles and their implications on physiological and pathological conditions is still not completely elucidated. However, evidence suggests microparticles released from platelets, leukocytes, and endothelium may help to evaluate vascular health as they have a relevant role in inflammation, endothelial function, and thrombosis. This review aims to provide a short overview of the biogenesis, characteristics, and detection methodology of microparticles with a special focus on their possible implication in cardiovascular settings.